Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dehydroepiandrosterone (DHEA) as Augmentation of Standard An-tidepressants in Treatment-resistant Depression: a Randomized Controlled Trial (DARE-Trial) - A Multicenter, Randomized, Double-blind, Placebo-controlled Trial With Group Sequential Design

NCT07843927 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT07843927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07843927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dehydroepiandrosterone (DHEA) as Augmentation of Standard An-tidepressants in Treatment-resistant Depression: a Randomized Controlled Trial (DARE-Trial) - A Multicenter, Randomized, Double-blind, Placebo-controlled Trial With Group Sequential Design
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 3
Overall status
Recruiting
Start date
June 22, 2026
Completion date
September 30, 2028
Enrollment
320 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression (trd)